Ives Jeffrey L. 4
4 · Acumen Pharmaceuticals, Inc. · Filed Jun 7, 2023
Insider Transaction Report
Form 4
Ives Jeffrey L.
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-06+25,000→ 25,000 totalExercise: $5.20Exp: 2033-06-05→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of June 6, 2024 or the 2024 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date.